Prevention and treatment of aortic graft infection

Expert Review of Anti-Infective Therapy

Volumn 5, Issue 2, 2007, Pages 305-315

  Mussa, Firas F ^a   Hedayati, Nasim ^a   Zhou, Wei ^a   El Sayed, Hosam F ^a   Kougias, Panagiotis ^a   Darouiche, Rabih O ^a   Lin, Peter H ^a  

^a MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Allograft; Aortoenteric fistula; Cryopreserved vascular graft; Extra anatomic bypass; Vascular graft excision; Vascular graft infection

Indexed keywords

ANTIBIOTIC AGENT; C REACTIVE PROTEIN; CLINDAMYCIN; COTRIMOXAZOLE; DACRON; DALFOPRISTIN PLUS QUINUPRISTIN; GENTAMICIN; LINEZOLID; POLITEF; RIFAMPICIN; VANCOMYCIN;

ANAMNESIS; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; AORTA GRAFT; AORTOGRAPHY; AUTOGRAFT; BACTERIUM CONTAMINATION; BLOOD CULTURE; BYPASS SURGERY; CLINICAL EXAMINATION; CLINICAL FEATURE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; DEBRIDEMENT; DIAGNOSTIC ACCURACY; DISEASE ASSOCIATION; ESCHERICHIA COLI; GRAFT INFECTION; GRAM STAINING; HUMAN; INFECTION CONTROL; KLEBSIELLA PNEUMONIAE; MORBIDITY; MORTALITY; PATHOPHYSIOLOGY; PHYSICAL EXAMINATION; PREOPERATIVE CARE; PROSTHESIS INFECTION; PROTEUS; PSEUDOMONAS; RADIODIAGNOSIS; REOPERATION; REVIEW; SALMONELLA; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; SURGICAL DRAINAGE; SURGICAL TECHNIQUE; TREATMENT DURATION;

ANIMALS; ANTI-BACTERIAL AGENTS; AORTA; BACTERIAL INFECTIONS; HUMANS; TRANSPLANTS; VASCULAR SURGICAL PROCEDURES;

EID: 34247646117     PISSN: 14787210     EISSN: 17448336     Source Type: Journal    
DOI: 10.1586/14787210.5.2.305     Document Type: Review

References (54)

1. Perera GB, Fujitani RM, Kubaska SM. Aortic graft infection: update on management and treatment options. Vasc. Endovasc. Surg. 40, 1-10 (2006).
2. Swain TW 3rd, Calligaro KD, Dougherty MD. Management of infected aortic prosthetic grafts. Vasc. Endovasc. Surg. 38, 75-82 (2004).
3. Torsello G, Sandmann W. Use of antibiotic-bonded grafts in vascular graft infection. Eur. J. Vasc. Endovasc. Surg. 14(Suppl. A), 84-87 (1997).
4. Reilly LM, Stoney RJ, Goldstone J, Ehrenfeld WK. Improved management of aortic graft infection: the influence of operation sequence and staging. J. Vasc. Surg. 5, 421-431 (1987).
5. Seeger JM, Pretus HA, Welborn MB, Ozaki CK, Flynn TC, Huber TS. Long-term outcome after treatment of aortic graft infection with staged extra-anatomic bypass grafting and aortic graft removal. J. Vasc. Surg. 32, 451-459; discussion 460-461 (2000).
6. Bandyk DF. Antibiotics - why so many and when should we use them? Semin. Vasc. Surg. 15, 268-274 (2002).
7. Bandyk DF, Esses GE. Prosthetic graft infection. Surg. Clin. North Am. 74, 571-590 (1994).
8. Bandyk DF, Novotney ML, Back MR, Johnson BL, Schmacht DC. Expanded application of in situ replacement for prosthetic graft infection. J. Vasc. Surg. 34, 411-419; discussion 419-420 (2001).
9. Calligaro KD, Veith FJ, Yuan JG, Gargiulo NJ, Dougherty MJ. Intraabdominal aortic graft infection: complete or partial graft preservation in patients at very high risk. J. Vasc. Surg. 38, 1199-1205 (2003).
10. Kieffer E, Gomes D, Chiche L, Fleron MH, Koskas F, Bahnini A. Allograft replacement for infrarenal aortic graft infection: early and late results in 179 patients. J. Vasc. Surg. 39, 1009-1017 (2004).
11. Lawrence PF. Management of infected aortic grafts. Surg. Clin. North Am. 75, 783-797 (1995).
12. Reilly L. Aortic graft infection: evolution in management. Cardiovasc. Surg. 10, 372-377 (2002).
13. Hayes PD, Nasim A, London NJ et al. In situ replacement of infected aortic grafts with rifampicin-bonded prostheses: the Leicester experience (1992 to 1998). J. Vasc. Surg. 30, 92-98 (1999).
14. Feliciano DV. Heroic procedures in vascular injury management: the role of extra-anatomic bypasses. Surg. Clin. North Am. 82, 115-124 (2002).
15. Brown PM Jr, Kim VB, Lalikos JF, Deaton DH, Bogey WM, Powell CS. Autologous superficial femoral vein for aortic reconstruction in infected fields. Ann. Vasc. Surg. 13, 32-36 (1999).
16. Clagett GP, Valentine RJ, Hagino RT. Autogenous aortoiliac/femoral reconstruction from superficial femoral-popliteal veins: feasibility and durability. J. Vasc. Surg. 25, 255-266; discussion 267-270 (1997).
17. Dorweiler B, Neufang A, Schmiedt W, Oelert H. Autogenous reconstruction of infected arterial prosthetic grafts utilizing the superficial femoral vein. Thorac. Cardiovasc. Surg. 49, 107-111 (2001).
18. Wilson SE. New alternatives in management of the infected vascular prosthesis. Surg. Infect. (Larchmt) 2, 171-175; discussion 175-177 (2001).
19. Chambers ST. Diagnosis and management of staphylococcal infections of vascular grafts and stents. Intern. Med. J. 35(Suppl. 2), S72-S78 (2005).
20. Belair M, Soulez G, Oliva VL et al. Aortic graft infection: the value of percutaneous drainage. Am. J. Roentgenol. 171, 119-124 (1998).
21. Scobie K, McPhail N, Barber G, Elder R. Bacteriologic monitoring in abdominal aortic surgery. Can. J. Surg. 22, 368-371 (1979).
22. Speziale F, Rizzo L, Sbarigia E et al. Bacterial and clinical criteria relating to the outcome of patients undergoing in situ replacement of infected abdominal aortic grafts. Eur. J. Vasc. Endovasc. Surg. 13, 127-133 (1997).
23. Bandyk DF, Kinney EV, Riefsnyder TI, Kelly H, Towne JB. Treatment of bacteria-biofilm graft infection by in situ replacement in normal and immune-deficient states. J. Vasc. Surg. 18, 398-405; discussion 405-406 (1993).
24. Yeager RA, Taylor LM Jr, Moneta GL et al. Improved results with conventional management of infrarenal aortic infection. J. Vasc. Surg. 30, 76-83 (1999).
25. Darling RC 3rd, Resnikoff M, Kreienberg PB et al. Alternative approach for management of infected aortic grafts. J. Vasc. Surg. 25, 106-112 (1997).
26. Oderich GS, Panneton JM. Aortic graft infection. What have we learned during the last decades? Acta. Chir. Belg. 102, 7-13 (2002).
27. Sicard GA, Reilly JM, Doblas M et al. Autologous vein reconstruction in prosthetic graft infections. Eur. J. Vasc. Endovasc. Surg. 14(Suppl. A), 93-98 (1997).
28. Benaerts PJ, Ridler BM, Vercaeren P, Thompson JF, Campbell WB. Gentamicin beads in vascular surgery: long-term results of implantation. Cardiovasc. Surg. 7, 447-450 (1999).
29. Busuttil SJ, Goldstone J. Diagnosis and management of aortoenteric fistulas. Semin. Vasc. Surg. 14, 302-311 (2001).
30. Oderich GS, Bower TC, Cherry KJ Jr et al. Evolution from axillofemoral to in situ prosthetic reconstruction for the treatment of aortic graft infections at a single center. J. Vasc. Surg. 43, 1166-1174 (2006).
31. Quinones-Baldrich WJ, Hernandez JJ, Moore WS. Long-term results following surgical management of aortic graft infection. Arch. Surg. 126, 507-511 (1991).
32. Reilly LM, Altman H, Lusby RJ, Kersh RA, Ehrenfeld WK, Stoney RJ. Late results following surgical management of vascular graft infection. J. Vasc. Surg. 1, 36-44 (1984).
33. Eriksson I, Forsberg O, Lundqvist B, Schwan A. Significant of positive bacterial cultures from aortic aneurysms. Acta Chir. Scand. 149, 33-35 (1983).
34. Cruse PJ, Foord R. A five-year prospective study of 23,649 surgical wounds. Arch. Surg. 107, 206-210 (1973).
35. Kuestner LM, Reilly LM, Jicha DL, Ehrenfeld WK, Goldstone J, Stoney RJ. Secondary aortoenteric fistula: contemporary outcome with use of extraanatomic bypass and infected graft excision. J. Vasc. Surg. 21, 184-195; discussion 195-196 (1995).
36. O'Hara PJ, Hertzer NR, Beven EG, Krajewski LP. Surgical management of infected abdominal aortic grafts: review of a 25-year experience. J. Vasc. Surg. 3, 725-731 (1986).
37. Walker WE, Cooley DA, Duncan JM, Hallman GL Jr, Ott DA, Reid GJ. The management of aortoduodenal fistula by in situ replacement of the infected abdominal aortic graft. Ann. Surg. 205, 727-732 (1987).
38. Bandyk DF, Bergamini TM, Kinney EV, Seabrook GR, Towne JB. In situ replacement of vascular prostheses infected by bacterial biofilms. J. Vasc. Surg. 13, 575-583 (1991).
39. Jacobs MJ, Reul GJ, Gregoric I, Cooley DA. In-situ replacement and extra-anatomic bypass for the treatment of infected abdominal aortic grafts. Eur. J. Vasc. Surg. 5, 83-86 (1991).
40. Bandyk DF, Novotney ML, Johnson BL, Back MR, Roth SR. Use of rifampinsoaked gelatin-sealed polyester grafts for in situ treatment of primary aortic and vascular prosthetic infections. J. Surg. Res. 95, 44-49 (2001).
41. Cagiannos C, Abul-Khoudoud OR, DeRijk W et al. Rapamycin-coated expanded polytetrafluoroethylene bypass grafts exhibit decreased anastomotic neointimal hyperplasia in a porcine model. J. Vasc. Surg. 42, 980-988 (2005).
42. Young RM, Cherry KJ Jr, Davis PM et al. The results of in situ prosthetic replacement for infected aortic grafts. Am. J. Surg. 178, 136-140 (1999).
43. D'Addato M, Curti T, Freyrie A. The rifampicin-bonded gelseal graft. Eur. J. Vasc. Endovasc. Surg. 14(Suppl. A), 15-17 (1997).
44. Calligaro KD, Veith FJ, Schwartz ML et al. Management of infected lower extremity autologous vein grafts by selective graft preservation. Am. J. Surg. 164, 291-294 (1992).
45. Nevelsteen A, Feryn T, Lacroix H, Suy R, Goffin Y. Experience with cryopreserved arterial allografts in the treatment of prosthetic graft infections. Cardiosvasc. Surg. 6, 378-383 (1998).
46. Noel AA, Gloviczki P, Cherry KJ Jr et al. Abdominal aortic reconstruction in infected fields: early results of the United States cryopreserved aortic allograft registry. J. Vasc. Surg. 35, 847-852 (2002).
47. Zhou W, Lin PH, Bush RL et al. In situ reconstruction with cryopreserved arterial allografts for management of mycotic aneurysms or aortic prosthetic graft infections: a multi-institutional experience. Tex. Heart Inst. J. 33, 14-18 (2006).
48. Rowe NM, Impellizzeri P, Vaynblat M et al. Studies in thoracic aortic graft infections: the development of a porcine model and a comparison of collagen-impregnated dacron grafts and cryopreserved allografts. J. Thorac. Cardiovasc. Surg. 118, 857-865 (1999).
49. Verhelst R, Lacroix V, Vraux H et al. Use of cryopreserved arterial homografts for management of infected prosthetic grafts: a multicentric study. Ann. Vasc. Surg. 14, 602-607 (2000).
50. Clagett GP, Bowers BL, Lopez-Viego MA et al. Creation of a neo-aortoiliac system from lower extremity deep and superficial veins. Ann. Surg. 218, 239-248; discussion 248-249 (1993).
51. Valentine RJ, Clagett GP. Aortic graft infections: replacement with autogenous vein. Cardiovasc. Surg. 9, 419-425 (2001).
52. Cardozo MA, Frankini AD, Bonamigo TP. Use of superficial femoral vein in the treatment of infected aortoiliofemoral prosthetic grafts. Cardiovasc. Surg. 10, 304-310 (2002).
53. Franke S, Voit R. The superficial femoral vein as arterial substitute in infections of the aortoiliac region. Ann. Vasc. Surg. 11, 406-412 (1997).
54. Gibbons CP, Ferguson CJ, Edwards K, Roberts DE, Osman H. Use of superficial femoropopliteal vein for suprainguinal arterial reconstruction in the presence of infection. Br. J. Surg. 87, 771-776 (2000).